RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Risks and Benefits of Conducting Preclinical Studies in the Global Setting

Risks and Benefits of Conducting Preclinical Studies in the Global Setting

Posted 01 December 2011 | By Mukesh KumarJanice Longstreth

It is generally accepted that the preclinical studies needed for first-in-man clinical studies usually take one to three years and cost up to $10 million USD, and the preclinical studies needed for market approval application cost about $70-$90 million.1

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.